» Articles » PMID: 1705417

Surgical Management of 552 Carcinomas of the Extrahepatic Bile Ducts (gallbladder and Periampullary Tumors Excluded). Results of the French Surgical Association Survey

Overview
Journal Ann Surg
Specialty General Surgery
Date 1991 Mar 1
PMID 1705417
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Five hundred fifty-two cases of primary carcinoma of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded) collected from 55 surgical centers were reviewed retrospectively. Three hundred seven patients (56%) had upper-third lesions (proximal carcinoma), whereas 71 (13%) and 101 (18%), respectively, had middle-third and lower-third bile duct carcinomas. The remaining patients had diffuse lesions. Resectability rates were 32% for upper-third localization compared to 47% and 51% for middle-third and lower-third localization, respectively. The operative mortality rate for proximal carcinomas was significantly lower with resection (16%) compared with palliative surgery (31%) (p less than 0.05). Overall 1-year survival (operative deaths excluded) was 68% after tumor resection compared to 31% after palliative surgery (p less than 0.001). Long-term results after surgical resection correlated with local and regional extension of the disease. The results of this study show that resection of extrahepatic bile duct carcinomas, particularly in an upper-third localization, often is associated with worthwhile long-term survival.

Citing Articles

Radiographic features predictive of recurrence and survival after surgical resection of perihilar cholangiocarcinoma.

Promsorn J, Naknan P, Sookprasert A, Wirasorn K, Chindaprasirt J, Titapun A Heliyon. 2024; 10(7):e28805.

PMID: 38617950 PMC: 11015104. DOI: 10.1016/j.heliyon.2024.e28805.


Predicting Disease-Specific Survival for Patients With Primary Cholangiocarcinoma Undergoing Curative Resection by Using a Decision Tree Model.

Quan B, Li M, Lu S, Li J, Liu W, Zhang F Front Oncol. 2022; 12:824541.

PMID: 35530339 PMC: 9071301. DOI: 10.3389/fonc.2022.824541.


Comparison of oncologic outcomes of extrahepatic cholangiocarcinoma according to tumor location: perihilar cholangiocarcinoma distal bile duct cancer.

Lee J, Kim H, Sohn H, Choi Y, Kang J, Han Y Ann Surg Treat Res. 2022; 102(2):100-109.

PMID: 35198513 PMC: 8831089. DOI: 10.4174/astr.2022.102.2.100.


Comparison of the clinical results of surgical resection for extrahepatic cholangiocarcinomas: Hilar cholangiocarcinoma and mid-to-distal cholangiocarcinoma.

Jung P, Cho E, Kim S, Kim R Ann Hepatobiliary Pancreat Surg. 2019; 23(4):319-326.

PMID: 31824996 PMC: 6893051. DOI: 10.14701/ahbps.2019.23.4.319.


Update on the management of cholangiocarcinoma.

Skipworth J, Keane M, Pereira S Dig Dis. 2014; 32(5):570-8.

PMID: 25034290 PMC: 4158615. DOI: 10.1159/000360507.


References
1.
KLATSKIN G . ADENOCARCINOMA OF THE HEPATIC DUCT AT ITS BIFURCATION WITHIN THE PORTA HEPATIS. AN UNUSUAL TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES. Am J Med. 1965; 38:241-56. DOI: 10.1016/0002-9343(65)90178-6. View

2.
Bismuth H, Corlette M . Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet. 1975; 140(2):170-8. View

3.
Shepherd H, Royle G, Ross A, Diba A, Arthur M, Colin-Jones D . Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg. 1988; 75(12):1166-8. DOI: 10.1002/bjs.1800751207. View

4.
Terblanche J, Kahn D, Bornman P, Werner D . The role of U tube palliative treatment in high bile duct carcinoma. Surgery. 1988; 103(6):624-32. View

5.
Yamakawa T, Esguerra Jr R, Kaneko H, Fukuma E . Percutaneous transhepatic endoprosthesis in malignant obstruction of the bile duct. World J Surg. 1988; 12(1):78-84. DOI: 10.1007/BF01658490. View